Vigil Neuroscience (VIGL)
(Delayed Data from NSDQ)
$3.68 USD
-0.07 (-1.87%)
Updated Sep 12, 2024 04:00 PM ET
3-Hold of 5 3
F Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Vigil Neuroscience, Inc. [VIGL]
Reports for Purchase
Showing records 1 - 20 ( 55 total )
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Steady As She Goes For VIGL With All Timelines On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
VG-3927 Off to a Good Start - Thoughts on sTREM2, sCSF-1R, and More
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Gearing Up For AAIC With Phase 1 VG-3927; AD Patient Data Tracking To 1Q25
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
FDA?s Willingness to Consider Accelerated Approval Pathway Encouraging Focus on NfL and vMRI Important; PT Down to $17
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Following FDA Interactions, VIGL Focuses on Final IGNITE Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Creative Financing Deal Offers Validation, Extends Runway
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Iluzanebart''s Accelerated Approval Depends on the NfL Data - Our Thoughts
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reproducible vMRI and NfL Data Critical for IGNITE 12-Month Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Looking Ahead To IGNITE In 3Q24; All Efforts On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Live From AD/PD Lisbon 2024-Microglia Plays a Crucial Role in Amyloid Cascade
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
2024 Sets Up To Be An Important Year For VIGL''''s Pipeline
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VIGL 112223
Provider: Stock Traders Daily
Analyst: Research Department